explore -WSS

explore

author：knowledge 2025-10-02 00:28:12 - browse：92

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Peter Hotez and the public health issue of online harassment
Next article： FTC loses bid to block Novant's North Carolina hospital merger

entertainment

WSS

Readout Newsletter: BridgeBio, Akero, and human embryo models

Medicare drug price negotiation continues, as pharma counteroffers

The untold story of TV’s first prescription drug ad

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

IVF doctors demand details after CooperSurgical lawsuit

Elevance PBM president out as customers face prescription chaos

Wikipedia

explore

focus

Continuity nursing helped my family in our darkest PICU moments

How CO2 helps viruses stay alive longer in the air

Medical records are filled with copy

How CO2 helps viruses stay alive longer in the air

How to save PrEP access — and even expand it

CMS got Medicare Advantage quality rating wrong, judge rules

In Memoriam: Notable people who died in 2023

A new initiative will help leaders fight the next pandemic

Walensky prepares to leave CDC — and Congress — behind

IVF doctors demand details after CooperSurgical lawsuit

knowledge

Take antibiotics after sex, CDC recommends for certain risk groups

Immune cells and nerve overgrowth may explain recurring UTI pain

Medicare drug price negotiation continues, as pharma counteroffers

Ancient Greek ideas underpin modern concepts of pregnancy

Biden's 'march

Eli Lilly’s Zepbound improved liver scarring in mid

entertainment

knowledge

leisure time

hotspot